Literature DB >> 11179352

Expression of C-reactive protein in the human respiratory tract.

J M Gould1, J N Weiser.   

Abstract

C-reactive protein (CRP) is a normal constituent of human sera synthesized by hepatocytes and induced by proinflammatory cytokines. The function of this acute-phase reactant includes activation of complement and enhancement of opsonophagocytosis. CRP binds to phosphorylcholine (ChoP), a constituent of eukaryotic membranes that is also found on the cell surface of major bacterial pathogens of the human respiratory tract, including Streptococcus pneumoniae and Haemophilus influenzae. The presence of CRP on mucosal surfaces and role in innate immunity in the human respiratory tract where ChoP-containing organisms reside have not been previously studied. We have shown using a monoclonal antibody to CRP that CRP is present in inflamed (0.17 to 42 microg/ml) and uninflamed (<0.05 to 0.88 microg/ml) secretions from the human respiratory tract in sufficient quantities for an antimicrobial effect. In addition, the CRP gene was expressed in epithelial cells of the human respiratory tract using in situ hybridization on nasal polyps and reverse transcriptase PCR of pharyngeal cells in culture. The complement-dependent bactericidal activity of normal nasal airway surface fluid and sputum against ChoP-expressing H. influenzae was abolished when the secretions were pretreated to remove CRP. In summary, the results indicate that CRP is present in secretions of the human respiratory tract, that human respiratory epithelial cells are capable of CRP expression, and that this protein may contribute to bacterial clearance in the human respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179352      PMCID: PMC98081          DOI: 10.1128/IAI.69.3.1747-1754.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor.

Authors:  W E Swords; B A Buscher; K Ver Steeg Ii; A Preston; W A Nichols; J N Weiser; B W Gibson; M A Apicella
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

2.  The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing.

Authors:  E Lysenko; J C Richards; A D Cox; A Stewart; A Martin; M Kapoor; J N Weiser
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

3.  Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases.

Authors:  H A Schenkein; J C Gunsolley; A M Best; M T Harrison; C L Hahn; J Wu; J G Tew
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

5.  Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract.

Authors:  E S Lysenko; J Gould; R Bals; J M Wilson; J N Weiser
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor.

Authors:  H A Schenkein; S E Barbour; C R Berry; B Kipps; J G Tew
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

8.  Interaction of rat serum phosphorylcholine-binding protein with phospholipid-containing liposomes.

Authors:  A Nagpurkar; U Saxena; S Mookerjea
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

9.  Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae.

Authors:  D M Musher; K R Kubitschek; J Crennan; R E Baughn
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

10.  Biosynthesis and postsynthetic processing of human C-reactive protein.

Authors:  A Tucci; G Goldberger; A S Whitehead; R M Kay; D E Woods; H R Colten
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

View more
  51 in total

Review 1.  Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

Authors:  Robert P Schleimer
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins.

Authors:  Ning Zhang; Quynh Ai Truong-Tran; Brian Tancowny; Kathleen E Harris; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

4.  Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.

Authors:  Jeroen D Langereis; Eva S van der Pasch; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo.

Authors:  Wenzhou Hong; Bing Pang; Shayla West-Barnette; W Edward Swords
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

7.  Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae.

Authors:  Kate L Fox; Jianjun Li; Elke K H Schweda; Varvara Vitiazeva; Katherine Makepeace; Michael P Jennings; E Richard Moxon; Derek W Hood
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria.

Authors:  Adam J Ratner; Jorge L Aguilar; Mikhail Shchepetov; Elena S Lysenko; Jeffrey N Weiser
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

Review 9.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

10.  C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.

Authors:  C M Eklund; T L J Tammela; J Schleutker; M Hurme
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.